Calcipotriol/Hydrocortisone

卡泊三醇/氢化可的松

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCalcipotriol/Hydrocortisone
Drug Alias Name氢化可的松/卡泊三醇Hydrocortisone/CalcipotriolCalcipotriol/CortisolLEO-80190
ClassificationSmall molecules > Steroids
Mechanisms of ActionVitamin D receptor antagonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorVitamin D receptor
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[8
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A